Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — Robert Califf, President Biden’s pick to lead the Food and Drug Administration, has asked Janet Woodcock, who has served as the FDA’s acting commissioner for the last 11 months, to stay on in a leadership role at the agency should he be confirmed by the Senate, two sources with knowledge of the discussion confirmed to STAT.

It’s still not clear exactly what Woodcock’s role would be or how she would split responsibilities with Califf, should she accept his offer. The most obvious role would be principal deputy commissioner, a position that amounts to second-in-charge at the agency and has been vacant since Amy Abernethy left it in April.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment